KCAS’s Dr Cheikh Kane will be presenting at the 24th Annual Immunogenicity & Bioassay Summit with Stephanie Pasas Farmer, PhD from Ariadne Software on “Using Random and Fixed Effects Modeling for a More Accurate Cut Point Determination”.

Presentation Description: Artificial Intelligence (AI) is increasing efficiencies in drug discovery and development by automating human tasks that are repetitive, demand accuracy and/or require immense resources. Using some case studies, we will highlight the benefits of AI solutions, as well as discuss challenges that the industry faces in the adoption of AI solutions, such as inadequate regulations, inaccessibility to quality development data, limited understanding of AI, cognitive biases, and implementation challenges.

This year’s Immunogenicity and Bioassay Summit will be held from October 3-7, 2022 at the Crystal Gateway Marriott in Washington D.C., United States of America.